CSR Analysts
You are here:HomeCSR AnalystsKey Indicators Economic indicators
CSR Analysts
Economic Indicators
Economic
| Unit | 2009 | 2010 | 2011 | |
|---|---|---|---|---|
| Sales | M€ | 131 327 | 159 269 | 184 693 |
| Adjusted operating income from business segments (1) | M€ | 14 154 | 19 797 | 24 409 |
| Adjusted net operating income from business segments (1) | M€ | 7 607 | 10 622 | 12 263 |
| Adjusted net income (Group share) (1) | M€ | 7 784 | 10 288 | 11 424 |
| Adjusted fully-diluted earnings per share (1) (2) | € | 3,48 | 4,48 | 5,06 |
| Dividend per share (3) | € | 2,28 | 2,28 | 2,28 |
| Net-debt-to-equity ratio (as of December 31) | % | 27 | 22 | 23 |
| Return on average capital employed (ROACE) (4) | % | 13 | 16 | 16 |
| Return on equity (ROE) | % | 16 | 19 | 18 |
| Cash flow from operating activities | M€ | 12 360 | 18 493 | 19 536 |
| Capital expenditure | M€ | 13 349 | 16 273 | 24 541 |
| Divestitures at selling prices | M€ | 3 081 | 4 316 | 8 578 |
1. Adjusted results are defined as income using replacement cost, adjusted for special items, excluding the impact of changes for fair value from January 1, 2011, and, through June 30, 2010, excluding Total’s equity share of adjustments related to Sanofi.
2. Based on the average weighted diluted shares outstanding during the year.
3. 2011 dividend; subject to approval at the Annual Shareholders’ Meeting on May 11, 2012.
4. Calculated based on adjusted net operating income and average capital employed, using replacement cost.
Boîte à outils
